Bristol-Myers, Sanofi Abused Plavix Patent: Apotex
Generic-drug maker Apotex Corp. has launched a new attack on Bristol-Myers Squibb Co. and Sanofi-Aventis' patent for blood-thinning drug Plavix, arguing in a new suit that it is unenforceable because Bristol-Myers...To view the full article, register now.
Already a subscriber? Click here to view full article